Table 2.
Drainage blood |
Peripheral blood |
|||||
Group A (non-metastatic) | Group B (metastatic) | P value | Group A (non-metastatic) | Group B (metastatic) | P value | |
RANTES (ng/mL) | 52.61 ± 35.37 | 95.17 ± 70.21 | 0.104 | 36.34 ± 23.64 | 66.60 ± 25.55 | 0.013 |
EGF (pg/mL) | 150.09 ± 70.40 | 270.67 ± 163.70 | 0.053 | 135.16 ± 67.01 | 289.36 ± 147.24 | 0.007 |
PDGFAA (ng/mL) | 2.30 ± 0.80 | 4.62 ± 1.60 | 0.001 | 2.38 ± 0.85 | 3.99 ± 1.46 | 0.007 |
HER2 (ng/mL) | 2.54 ± 0.68 | 2.95 ± 1.02 | 0.296 | 2.01 ± 0.55 | 2.91 ± 0.49 | 0.001 |
MMP7 (ng/mL) | 2.77 ± 1.47 | 4.57 ± 2.70 | 0.080 | 2.20 ± 1.08 | 3.98 ± 2.10 | 0.028 |
Values are presented as mean ± SD. RANTES: Regulated on activation normal T cell expressed and secreted; EGF: Epidermal growth factor; PDGFAA: Platelet-derived growth factor AA; HER2: Human epidermal growth factor receptor 2; MMP7: Matrix metalloproteinase 7.